Ganz, while I wouldn't argue with you about doubling being extremely conservative; you still have to keep in mind my buddy in the IR office. Upon FDA approval, there's going to be selling pressure because of folks like me that feels the world doesn't need another pharmaceutical company.
I believe we'll run up the week of Jan. 22, and I'll be a seller into that run, then after approval, I'll sell another third of my holdings leaving me with a third to see exactly what the hell happens.
If history proves that you're wrong, doubling was actually ultra conservative, than good luck to you guys. I'll just claim that my DES is really me crying for myself.
Nice run today, hope everyone has a fun, safe weekend and Holiday.
As for SUVRF, I'm catching up with you while lowering my cost basis, to boot.
News 
Market Data 
Discover 
AI
